MedTrace Logo

Continous Quadratus Lumborum Block for Hepatic Surgery With Right Subcostal Incision

NCT02914015 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-09-04

No results posted yet for this study

Summary

This prospective, randomized study, control study aims to compare the analgesic effect, opioids consumption, quality of recovery, length of hospital stay and et al. between unilateral continuous quadratus lumborum block (QLB) and intravenous patient-controlled analgesia (IPCA) alone in patients undergoing hepatectomy with right J-shape subcostal incision.

Conditions

  • Hepatectomy
  • Analgesia
  • Nerve Block

Interventions

PROCEDURE

Continous QLB (quadratus lumborum block)

Inject local anesthetics in between quadratus lumborum and psoas major muscle with catheter insertion and continuous local infusion

DEVICE

Philip CX50 Ultrasound Scanner

The curved (C1-5) probe of Philip CX 50 Ultrasound Scanner is used for scan

DRUG

Ropivacaine

* 0.6ml/kg 0.5% ropivacaine with 1:200,000 adrenaline given immediately after the correct position of the tip of the needle has been verified. * followed with 0.2% ropivacaine infusion at a rate of 0.125ml/kg/h given through the catheter inserted in between the quadratus lumborum muscle and psoas major muscle.

DRUG

Morphine given as IPCA

Bolus: 1-2mg, lock time: 10min, 1h limitation: 5-10mg. without background infusion.

Sponsors & Collaborators

  • Cui Xulei

    lead OTHER

Principal Investigators

  • Yuguang Huang, MD. · Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2019-05-29
Completion
2019-05-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02914015 on ClinicalTrials.gov